Who Paid My Doc
Alan Vainrib
Cardiovascular Disease New York, NY Medical Doctor
NPI 1598918005 CMS profile 1300144
Cumc, Ft. Washington Ave., New York, NY 10025
General payments
$34,765
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Alan Vainrib of New York, NY is reported in the CMS Open Payments database as having received $34,765 across 62 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 92nd percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $12,427 | 17 | |
| 2024 | General | $8,387 | 12 | |
| 2023 | General | $12,853 | 21 | |
| 2022 | General | $238 | 1 | |
| 2021 | General | $269 | 3 | |
| 2020 | General | $28 | 1 | |
| 2019 | General | $562 | 7 |
Beside peers
- Alan Vainrib
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Alan Vainrib were reported at $12,427. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Alan Vainrib | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $562 | $450 | $127–$1,392 | $163 |
| 2020 | $28 | $242 | $77–$751 | $114 |
| 2021 | $269 | $335 | $101–$1,037 | $132 |
| 2022 | $238 | $395 | $121–$1,211 | $149 |
| 2023 | $12,853 | $443 | $136–$1,283 | $160 |
| 2024 | $8,387 | $450 | $136–$1,323 | $164 |
| 2025 | $12,427 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$152,828
Medicare patients
1,066
Services billed
10,863
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 73% | |
| Arthritis | 59% | |
| Heart failure | 58% | |
| Atrial fibrillation | 48% | |
| Chronic kidney disease | 45% | |
| Diabetes | 42% | |
| COPD | 28% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 132 | 8,630 | $895 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
62 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in New York
Roger Hajjar
Cardiovascular Disease · New York, NY
Szilard Voros
Cardiovascular Disease · Stony Brook, NY
Gregg Stone
Cardiovascular Disease · New York, NY
Augustin Delago
Cardiovascular Disease · Albany, NY
Philippe Genereux
Cardiovascular Disease · New York, NY
Adam Rosenbluth
Cardiovascular Disease · New York, NY
Related records
Cardiovascular Disease in New York
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.